Atlas Trials

Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.

Clinical trial NCT02887677 · TERMINATED

Trial details

NCT number
NCT02887677
Sponsor
Hellenic Society for Medical Education
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2016-10-01
Primary completion
2019-06-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.